TY - JOUR
T1 - Epidemiological profile of patients with multiple myeloma who developed pulmonary complications after hematopoietic stem cell transplantation
AU - Chacón Manosalva, Jaime Leonardo
AU - Salazar Montaña, Luis Antonio
AU - Peña Castellanos, Angela María
AU - Jurado, Jonathan Javier Díaz
AU - Prada Sepulveda, Ana Maria
AU - Vera, Miguel Enrique Ochoa
AU - Vesga Jerez, Gabriela
AU - Chacon Manosalva, Maria Angelica
AU - Sossa Melo, Claudia Lucia
A2 - Rosales Acevedo, Manuel Leonidas
PY - 2022/11/1
Y1 - 2022/11/1
N2 - Multiple myeloma (MM) is a neoplastic entity for which Hematopoietic Stem Cell Transplantation (HSCT) is a therapeutic option. Between 30–60% of patients managed with HSCT have pulmonary complications (PC). The aim of this study was to identify the clinical and sociodemographic characteristics associated with the incidence of PC in patients with MM after HSCT (post-HSCT) at Clinica FOSCAL.
AB - Multiple myeloma (MM) is a neoplastic entity for which Hematopoietic Stem Cell Transplantation (HSCT) is a therapeutic option. Between 30–60% of patients managed with HSCT have pulmonary complications (PC). The aim of this study was to identify the clinical and sociodemographic characteristics associated with the incidence of PC in patients with MM after HSCT (post-HSCT) at Clinica FOSCAL.
KW - mulplipe myeloma
U2 - 10.1038/s41409-022-01798-0
DO - 10.1038/s41409-022-01798-0
M3 - Artículo Científico
SN - 0268-3369
VL - 57
SP - 324
EP - 325
JO - Bone Marrow Transplantation
JF - Bone Marrow Transplantation
IS - pag. 326
M1 - P412
ER -